[ad_1]
MANILA, Philippines – After authorities noted the difficulty of enrolling participants in the clinical trial of the Japanese influenza drug Avigan, the Department of Health (DOH) said Wednesday that the recruitment protocol for the study was long overdue in the Philippines. streamlined to recruit more patients.
According to the Undersecretary of Health, María Rosario Vergeire, the study so far has only eight participants to test the effectiveness of Avigan in treating the disease.
READ: DOH notes low participation in Avigan clinical trials
Vergeire said the revised protocol, which has already been approved, would allow non-severe COVID-19 patients, those with or without pneumonia, and those not receiving high-flow oxygen support, to participate in clinical trials.
“From 96 participants, it has expanded to 144 kaya, hopefully we can already reach the iyong number without a large number of samples needed to complete this clinical trial,” Vergeire told reporters in an online briefing.
The trial was initially scheduled to begin in mid-July, but was delayed when legal arrangements were finalized.
The Japanese government delivered a sufficient supply of tablets in early August for 100 patients who would participate in clinical trials.
KGA
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our leaders in healthcare and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
